CD39 (ENTPD1) drugs for Non-Small Cell Lung Cancer
2 tracked CD39 (ENTPD1) drugs in the Non-Small Cell Lung Cancer race. The class explanation lives on the CD39 (ENTPD1) page; the full indication pipeline across every mechanism is on the Non-Small Cell Lung Cancer page.
1 Phase 21 Phase 1